Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study.

Panettieri, Reynold A

Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study. [electronic resource] - Clinical therapeutics Aug 2009 - 1716-23 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1879-114X

10.1016/j.clinthera.2009.08.012 doi


Administration, Inhalation
Adrenergic beta-Agonists--administration & dosage
Aged
Area Under Curve
Bronchodilator Agents--administration & dosage
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Ethanolamines--administration & dosage
Female
Forced Expiratory Volume--drug effects
Formoterol Fumarate
Humans
Least-Squares Analysis
Male
Middle Aged
Nebulizers and Vaporizers
Pulmonary Disease, Chronic Obstructive--drug therapy
Severity of Illness Index
Time Factors